Early Markers
PrivateLast Round
Grant
Jul 3, 2024
Total Funding Raised
$2.57M
Company Overview
Early Markers operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Grant round in September 2018.
Early Markers is a health technology company that develops AI-powered smartphone-based screening tools for the early identification of neuromotor risks in infants.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Early Markers Comparables
Compare Early Markers with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Twinsee | 84% | |
| PediaMetrix | 70% | |
| NeuralClinic Ai | 69% |
For institutional investors. Book with your work email.
Early Markers Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 3, 2024 | ||||
| Grant | Sep 14, 2018 |
For institutional investors. Book with your work email.
Early Markers Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2024
$309K grant received from NIH and NICHD.
- Sep 14, 2018
Secured $2M from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
For institutional investors. Book with your work email.
Early Markers Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Early Markers's valuation, stock price, and market status.
Is Early Markers a public or private company?
Early Markers is a private company.
What is the current stock price of Early Markers?
Early Markers is a private company, so its shares have no public market price. Caplight tracks Early Markers's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Early Markers worth (valuation)?
Valuation information for Early Markers is not publicly available.
Can I buy Early Markers stock?
Early Markers shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Early Markers's last funding round?
Early Markers's most recent funding round was Grant on July 3, 2024.
Who are the main investors in Early Markers?
Key investors in Early Markers include Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Mental Health.
Will Early Markers IPO soon?
No public IPO plans have been announced for Early Markers.
How can I track Early Markers secondary market activity?
Caplight tracks bids, offers, and trades in Early Markers's shares on secondary markets.